Sandbox: malabsorption: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 7: | Line 7: | ||
{| class="wikitable" style="border: 0px; font-size: 100%; margin: 3px;" align="center" | {| class="wikitable" style="border: 0px; font-size: 100%; margin: 3px;" align="center" | ||
! rowspan="5" style="background:#4479BA; color: #FFFFFF;" align="center" |Cause | ! rowspan="5" style="background:#4479BA; color: #FFFFFF;" align="center" |Cause | ||
| colspan=" | | colspan="9" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Clinical manifestation''' | ||
! colspan="9" rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Lab findings''' | ! colspan="9" rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Lab findings''' | ||
! rowspan="5" style="background:#4479BA; color: #FFFFFF;" align="center" |Extra intestinal findings | ! rowspan="5" style="background:#4479BA; color: #FFFFFF;" align="center" |Extra intestinal findings | ||
Line 13: | Line 13: | ||
! rowspan="5" style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard diagnosis | ! rowspan="5" style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard diagnosis | ||
|- | |- | ||
! colspan=" | ! colspan="8" style="background:#4479BA; color: #FFFFFF;" align="center" |Symptoms | ||
! rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |GI signs | ! rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |GI signs | ||
|- | |- | ||
Line 20: | Line 20: | ||
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Fever | ! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Fever | ||
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Abdominal pain | ! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Abdominal pain | ||
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Weight loss | ! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Weight loss | ||
! | ! | ||
Line 50: | Line 49: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 90: | Line 88: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 129: | Line 126: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 163: | Line 159: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 197: | Line 192: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 239: | Line 233: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 270: | Line 263: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="Left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="Left" | | ||
Line 311: | Line 303: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="Left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="Left" | | ||
Line 341: | Line 332: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 374: | Line 364: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 403: | Line 392: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 438: | Line 426: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 477: | Line 464: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 515: | Line 501: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 550: | Line 535: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 578: | Line 562: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 613: | Line 596: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 652: | Line 634: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 691: | Line 672: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 729: | Line 709: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 762: | Line 741: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 796: | Line 774: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 820: | Line 797: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 844: | Line 820: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 868: | Line 843: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 892: | Line 866: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 916: | Line 889: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 940: | Line 912: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 964: | Line 935: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 997: | Line 967: | ||
|- | |- | ||
! | ! | ||
| colspan=" | | colspan="9" |'''Clinical manifestation''' | ||
! colspan="9" rowspan="3" |'''Lab findings''' | ! colspan="9" rowspan="3" |'''Lab findings''' | ||
! rowspan="5" |Extra intestinal findings | ! rowspan="5" |Extra intestinal findings | ||
Line 1,004: | Line 974: | ||
|- | |- | ||
! style="background:#DCDCDC;" align="center" | | ! style="background:#DCDCDC;" align="center" | | ||
! colspan=" | ! colspan="8" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Symptoms | ||
! rowspan="4" style="padding: 5px 5px; background: #F5F5F5;" align="left" |GI signs | ! rowspan="4" style="padding: 5px 5px; background: #F5F5F5;" align="left" |GI signs | ||
|- | |- | ||
Line 1,012: | Line 982: | ||
! rowspan="3" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Fever | ! rowspan="3" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Fever | ||
! rowspan="3" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Abdominal pain | ! rowspan="3" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Abdominal pain | ||
! rowspan="3" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Weight loss | ! rowspan="3" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Weight loss | ||
|- | |- | ||
! style="background:#DCDCDC;" align="center" | | ! style="background:#DCDCDC;" align="center" | | ||
! colspan="5" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Stool exam | ! colspan="5" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Stool exam | ||
| colspan="3" style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''CBC''' | | colspan="3" style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''CBC''' | ||
Line 1,027: | Line 995: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Bloody | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Bloody | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Fatty | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Fatty | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |WBC | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |WBC | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |RBC | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |RBC | ||
Line 1,045: | Line 1,012: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 1,075: | Line 1,041: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 1,105: | Line 1,070: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 1,135: | Line 1,099: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 1,165: | Line 1,128: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 1,198: | Line 1,160: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 1,231: | Line 1,192: | ||
! | ! | ||
!+ | !+ | ||
!- | !- | ||
! | ! | ||
Line 1,255: | Line 1,215: | ||
!- | !- | ||
!+ | !+ | ||
!+/- | !+/- | ||
! | ! |
Revision as of 15:59, 11 December 2017
Diarrhea
Abbreviations: GI: Gastrointestinal; WBC: White blood cells; Plt: Platelets, Hgb: Hemoglobin, IgE: Immunoglobulin E, IgA: Immunoglobulin A
Cause | Clinical manifestation | Lab findings | Extra intestinal findings | Cause/Pathogenesis | Gold standard diagnosis | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | GI signs | ||||||||||||||||||||
Duration | Diarrhea | Fever | Abdominal pain | Weight loss | |||||||||||||||||
Stool exam | CBC | Other lab findings | |||||||||||||||||||
Acute | Chronic | Watery | Bloody | Fatty | WBC | RBC | Ova/Parasite | Osmotic gap | Other | WBC | Hgb | Plt | |||||||||
Whipple's disease | - | + | + | - | + | ± | + | + | - | - | - | ↑ | ↓ | ↓ | ↓/↑ |
| |||||
Celiac disease | - | + | ± | - | ± | - | + | + | ↑ | - | ↓ | - |
|
|
|
||||||
Tropical sprue | + | + | + | - | + | + | + | + |
|
↑ | - | ↓ | - |
|
| ||||||
Crohns disease | - | + | + | + | + | + | + | + | - | ↑ | ↓ | ↑ |
|
|
|
| |||||
Ulcerative colitis | - | + | + | + | + | + | + | + | - | ↑ | ↓ | ↑ |
|
|
| ||||||
Cystic fibrosis | - | + | - | - | + | ± | + | + | ↑ | - | ↓ | - |
|
|
| ||||||
VIPoma | + | + | + | - | + | - | + | + |
|
↓ | - | - | - |
|
|
| |||||
Zollinger-Ellison syndrome | - | + | + | - | + | - | + | + | ↓ | - | ↓ | - |
|
| |||||||
Eosinophilic gastroenteritis | - | + | + | - | + | - | + | + | ↑ | - | - |
|
|
|
| ||||||
Primary bile acid malabsorption | - | + | + | - | + | - | + | + | ↑ | - | ↓ | - |
|
|
| ||||||
Abetalipoproteinemia | - | + | + | - | + | - | + | + | - | - | - |
|
|
|
| ||||||
Microscopic colitis | - | + | + | + | - | - | + | + | - | - | ↓ | - |
|
|
|
| |||||
Hyperthyroidism | - | + | + | - | - | ± | + | + | - | - | - |
|
|||||||||
Lactose intolerance | + | + | + | - | - | - | + | - | ↑ | - | - | - |
|
|
| ||||||
Irritable bowel syndrome | - | + | ± | - | ± | - | ± | - |
|
- | - | - | - |
| |||||||
Chronic pancreatitis | - | + | + | - | + | - | + | + | ↑ | - | - | - |
|
|
|||||||
Cirrhosis | - | + | + | - | + | + | + | + |
|
↑ | ↓ | ↓ | ↓ |
|
|
|
| ||||
Short bowel syndrome | + | + | + | - | + | - | - | + |
|
↑ | - | ↓ | ↑ |
|
|
|
|||||
Small bowel bacterial overgrowth | - | + | + | - | + | - | + | + | - | ↓ | - |
|
|
| |||||||
X-linked agammaglobulinemia | - | + | + | - | + | + | + | + |
|
- | ↓ | ↓ | - |
|
|
|
| ||||
Intestinal lymphangiectasia | - | + | - | - | + | - | - | + |
|
- | ↓ | - | - |
|
|
|
Intestinal biopsy | ||||
Amyloidosis | + | ||||||||||||||||||||
Mastocytosis | |||||||||||||||||||||
Drug induced enteritis | |||||||||||||||||||||
Giardiasis | + | ||||||||||||||||||||
Strongyloidiasis | |||||||||||||||||||||
Tuberculosis | |||||||||||||||||||||
Chronic laxative abuse | |||||||||||||||||||||
Pseudomembranous colitis | + | - | + | +/- | - | + | + | +/- |
|
|
↑ | ↓ | ↓ |
|
|
| |||||
Clinical manifestation | Lab findings | Extra intestinal findings | Cause/Pathogenesis | Gold standard diagnosis | |||||||||||||||||
Symptoms | GI signs | ||||||||||||||||||||
Duration | Diarrhea | Fever | Abdominal pain | Weight loss | |||||||||||||||||
Stool exam | CBC | Other lab findings | |||||||||||||||||||
Acute | Chronic | Watery | Bloody | Fatty | WBC | RBC | Ova/Parasite | Osmotic gap | Other | WBC | Hgb | Plt | |||||||||
CMV collitis | + | + | +/- | + | - |
|
+/- | + | - | - |
|
↓ | - | - |
|
|
|
| |||
Macrobacterium Aviom Complex | + | + | +/- | + | - |
|
+/- | + | - | - |
|
↓ | - | - |
|
|
|
| |||
Colon cancer | + | + | + | + |
|
- | + | - | - |
|
- | ↑/↓ | - |
|
|
|
| ||||
Intestinal metastasis | + | + | + | + |
|
- | + | - | - |
|
↑/↓ | ↑/↓ | ↑/↓ |
|
|
|
| ||||
Infectious Diarrhea | + | + | - | + | +/- |
|
+ | + | - | - |
|
↑ | - | - |
|
|
|
| |||
Infectious Diarrhea | + | + | + | + | - |
|
+ | + | - | - |
|
↑ | - | - |
|
|
|
| |||
Isosporiasis | + | + | + | - | + | + | - | - | ↑ | - | |||||||||||
Parasitic Diarrhea | + | + | + | - | + | +/- | + | + | + | - | ↑ | - | - | Amebiasis
Intestinal Schistosomiasis Balantidiasis Trichuriasis |